Skip to Content

Onexton Approval History

FDA Approved: Yes (First approved November 25, 2014)
Brand name: Onexton
Generic name: benzoyl peroxide and clindamycin phosphate
Dosage form: Gel
Company: Bausch Health Companies Inc.
Treatment for: Acne

Onexton (benzoyl peroxide and clindamycin phosphate) is an antimicrobial and lincosamide antibacterial combination for the once-daily topical treatment of acne vulgaris.

Development History and FDA Approval Process for Onexton

DateArticle
Nov 25, 2014Approval Valeant Pharmaceuticals Announces FDA Approval of Onexton Gel for Acne Vulgaris

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide